In conclusion, the current study shows that APOC1 was highly expressed in TAMs of CRC tissues based on scRNA-seq and bioinformatics analysis and that inhibiting APOC1 of TAMs slowed CRC progression in vitro, offering a novel approach and giving CRC patients fresh hope. Here, APOC1 is linked to colorectal carcinoma.